Infectious disease expert says White House 'caving to anxious Americans' on COVID-19 boosters

The Biden administration's determination to make COVID-19 booster shots widely available may be undermining confidence in the available vaccines, Paul Offit, the director of the Vaccine Education Center at Children's Hospital of Pennsylvania, told The Atlantic.
"Whether it's the Pfizer, Moderna, or Johnson & Johnson, you consistently have excellent protection against severe illness," he said, adding that that hasn't changed despite an increasing number of breakthrough infections.
Now, Offit said he's hearing from people who are nervous about losing their immunity if they don't get a booster quickly. "We've scared people into thinking they're no longer protected," he said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Céline Grounder, an infectious disease expert and epemiologist who once served as a member of Biden's transition-team COVID-19 advisory board, has a slightly view of the situation. She thinks that the general anxiety about breakthrough cases among President Biden's base of voters is actually influencing the White House's messaging, rather than the other way around. "They're caving to anxious Americans who want as many doses as possible of the vaccine as possible because they're fearful of what breakthrough infections could mean," Grounder told The Atlantic. Read more at The Atlantic.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Mitch McConnell won't seek reelection
Speed Read The longest-serving Senate party leader is retiring
By Rafi Schwartz, The Week US Published
-
Trump reportedly wants to take over US Postal Service
Speed Read President Trump is making plans to disband the leadership of USPS and absorb the agency into his administration
By Peter Weber, The Week US Published
-
The week's best photos
A moment of balance, a daring leap, and more
By Anahi Valenzuela, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published